How I treat monoclonal gammopathy of renal significance (MGRS)
Jean-Paul Fermand(Hôpital Saint-Louis), Nelson Leung(WinnMed), Efstathios Kastritis(National and Kapodistrian University of Athens), Angela Dispenzieri(Mayo Clinic), Mark T. Drayson(Institute of Immunology), Mark Cook(Université Paris Cité), Frank Bridoux(Université de Poitiers), Robert A. Kyle(Mayo Clinic), Brendan M. Weiss(Heidelberg University)
Cited by 319
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
|New England Journal of Medicine|2003|1.8k